Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
χ<sup>2</sup> tests showed that XRCC1-194, XRCC1-280 and XPD-312 gene polymorphisms were significantly correlated with the number, location and diameter of the tumors (p<0.05).
|
28927037 |
2017 |
Xeroderma Pigmentosum, Complementation Group D
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
[Quantitative electron microscopy of the normal human lymphocyte (author's transl)].
|
601675 |
1977 |
Photosensitive Trichothiodystrophy
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
[Quantitative electron microscopy of the normal human lymphocyte (author's transl)].
|
601675 |
1977 |
Squamous cell carcinoma
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
[Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
|
12579497 |
2003 |
Adenocarcinoma
|
0.050 |
GeneticVariation
|
group |
LHGDN |
[Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
|
12579497 |
2003 |
Occupational Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
[Association between polymorphisms of XPD gene and susceptibility to chronic benzene poisoning].
|
16889696 |
2006 |
Adenoma of large intestine
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
|
17164360 |
2006 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
XRCC1, XRCC2, TP53, and ERCC2 variants were each nominally associated with several types of cancer.
|
19116388 |
2009 |
Primary malignant neoplasm
|
0.100 |
GeneticVariation
|
group |
BEFREE |
XRCC1, XRCC2, TP53, and ERCC2 variants were each nominally associated with several types of cancer.
|
19116388 |
2009 |
Squamous cell carcinoma
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population.
|
17556064 |
2007 |
Age-related cataract
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
|
25873778 |
2015 |
Cockayne Syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.
|
17466625 |
2007 |
Malignant Head and Neck Neoplasm
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis.
|
11133811 |
2000 |
Head and Neck Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis.
|
11133811 |
2000 |
Skin Neoplasms
|
0.330 |
GeneticVariation
|
group |
LHGDN |
XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
|
15298945 |
2004 |
Neoplasms, Second Primary
|
0.010 |
GeneticVariation
|
phenotype |
LHGDN |
XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
|
15298945 |
2004 |
Xeroderma Pigmentosum, Complementation Group D
|
1.000 |
Biomarker
|
disease |
CLINGEN |
XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha.
|
11955452 |
2002 |
Mammary Neoplasms
|
0.070 |
GeneticVariation
|
group |
LHGDN |
XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer.
|
18459458 |
2007 |
Xeroderma Pigmentosum
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
XPB or XPD missense mutations lead to Xeroderma pigmentosum, Cockayne's syndrome, Trichothiodystrophy, or COFS syndrome, suggesting that DNA repair and transcription defects are responsible for clinical heterogeneity.
|
23276657 |
2015 |
Trichothiodystrophy Syndromes
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
XPB and XPD genetic defects can also cause premature aging with profound neurological defects without increased cancers: Cockayne syndrome (CS) and trichothiodystrophy (TTD).
|
21571596 |
2011 |
Cockayne Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
XPB and XPD genetic defects can also cause premature aging with profound neurological defects without increased cancers: Cockayne syndrome (CS) and trichothiodystrophy (TTD).
|
21571596 |
2011 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
XPB and XPD genetic defects can also cause premature aging with profound neurological defects without increased cancers: Cockayne syndrome (CS) and trichothiodystrophy (TTD).
|
21571596 |
2011 |
Premature aging syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
XPB and XPD genetic defects can also cause premature aging with profound neurological defects without increased cancers: Cockayne syndrome (CS) and trichothiodystrophy (TTD).
|
21571596 |
2011 |
nervous system disorder
|
0.010 |
GeneticVariation
|
group |
BEFREE |
XPA and XPD and others can cause childhood XP neurological disease with widespread neuronal loss, axonal sensorimotor neuropathy, and dwarfing.
|
23622385 |
2013 |
Xeroderma Pigmentosum
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
XPA and XPD and others can cause childhood XP neurological disease with widespread neuronal loss, axonal sensorimotor neuropathy, and dwarfing.
|
23622385 |
2013 |